The problem of "protopathic bias" in case-control studies

Area of Science:

• Epidemiology
• Medical Research Methodology

Background:

• Case-control studies are susceptible to various biases.
• Protopathic bias arises when a drug is prescribed for undetected early disease manifestations.

Purpose of the Study:

• To demonstrate protopathic bias in pharmaceutical research.
• To highlight the impact of this bias on study findings, using specific examples.

Main Methods:

• Review of case-control studies examining drug effects.
• Analysis of patient-reported reasons for medication use prior to diagnosis.

Main Results:

• In an estrogens and endometrial cancer study, 10% of estrogen users received prescriptions for uterine bleeding before cancer diagnosis.
• Similar findings were observed in other studies, indicating a pattern of protopathic bias.

Conclusions:

• Empirical evidence confirms the occurrence of protopathic bias in medical research.
• This bias can significantly affect the interpretation of results, particularly in drug-disease association studies.
• Careful methodological precautions are essential to mitigate protopathic bias.